ClinicalTrials.govpublic full text
SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.
bone marrow diseases, myelodysplastic syndromes, hematologic diseases, bone marrow neoplasms, p38 map kinase, scio-469, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 806792
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.